Cargando…
Erythropoietin and organ protection: lessons from negative clinical trials
Based on its pleiotropic effects, erythropoietin can decrease inflammation, oxidative stress, and apoptosis. Erythropoietin provides organ protection for the heart, brain, and kidney in diverse preclinical animal studies, especially models that include ischemia–reperfusion injury and/or inflammation...
Autor principal: | Pearl, Ronald G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331307/ https://www.ncbi.nlm.nih.gov/pubmed/25672222 http://dx.doi.org/10.1186/s13054-014-0526-9 |
Ejemplares similares
-
Is the β Common Receptor the Key Molecule for the Protective Effect of Erythropoietin?
por: Yang, Zhenhong, et al.
Publicado: (2023) -
Beneficial effects of erythropoietin in preclinical models of shock and organ failure
por: Thiemermann, Christoph
Publicado: (2007) -
Focal adhesion kinase and actin regulatory/binding proteins that modulate F-actin organization at the tissue barrier: Lesson from the testis
por: Cheng, C. Yan, et al.
Publicado: (2013) -
Conflicting clinical trial data: a lesson from albumin
por: Martin, Greg
Publicado: (2005) -
Erythropoietin for stroke treatment: dead or alive?
por: Minnerup, Jens, et al.
Publicado: (2011)